Sativex (cannabis-derived) Trial Planned For Alzheimer’s

UK researchers are launching a trial looking at a cannabis-based therapy for Alzheimer’s

The study team plans to recruit volunteers between 55 and 90 years of age who have symptoms of agitation or aggression. The volunteers will be split into two groups: those who receive Sativex and those who receive a placebo. After four weeks, researchers will evaluate the results.


Leave a Reply

Your email address will not be published. Required fields are marked *